Y Intercept Hong Kong Ltd Takes Position in The Cooper Companies, Inc. (NASDAQ:COO)

Y Intercept Hong Kong Ltd purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 21,591 shares of the medical device company’s stock, valued at approximately $1,985,000.

Other large investors have also added to or reduced their stakes in the company. Ashton Thomas Securities LLC bought a new position in Cooper Companies in the 3rd quarter valued at approximately $25,000. Covestor Ltd raised its holdings in Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after buying an additional 200 shares during the last quarter. Byrne Asset Management LLC bought a new position in Cooper Companies in the 4th quarter valued at approximately $33,000. Brown Brothers Harriman & Co. raised its holdings in Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after buying an additional 275 shares during the last quarter. Finally, West Financial Advisors LLC bought a new position in Cooper Companies in the 4th quarter valued at approximately $49,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ:COO opened at $90.26 on Wednesday. The company has a fifty day moving average of $92.78 and a 200-day moving average of $99.61. The firm has a market capitalization of $18.01 billion, a P/E ratio of 46.29, a P/E/G ratio of 2.25 and a beta of 1.00. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the previous year, the business posted $0.87 EPS. Cooper Companies’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Wells Fargo & Company raised their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Citigroup lowered their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Morgan Stanley lowered their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and an average target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.